IRCT2014080717325N2CompletedPhase 2
The effect of Silybum marianum in treatment and prevention of hepatotoxicity in patients undergoing induction therapy for acute lymphoblastic leukemia
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Enrollment
- 30
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 30 days to 14 years (—)
- Sex
- All
Inclusion Criteria
- •Children aged under 15 with a diagnosis of acute lymphoblastic leukemia undergoing induction therapy Exclusion criteria: Patients with liver diseases or diabetes
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Recruiting
Phase 2
The effect of Silybum Marianum on treatment of migraineMigraine.MigraineIRCT2016022026667N1Arak University of Medical Sciences60
Completed
Phase 2
The effects of Silybum marianum (L.) Gaertn. (Silymarin) supplement consumption on metabolic status, Hs-CRP and oxidative stress in type 2 diabetic patients with overweight or obesityType 2 diabetes.Non-insulin-dependent diabetes mellitusE10,E11,E1IRCT201309243140N13Vice chancellor for Research, Tabriz University of Medical Sciences40
Not yet recruiting
Phase 2
Effect of Silybum marianum, Melissa officinalis, Vaccinium arctostaphylos, Trigonella foenum, Urtica dioica, and Citrullus colocynthis extract mixture on blood sugar control in type 2 diabetic patientsIRCT20080901001157N15Iranian academic center for education culture and research60
Recruiting
Phase 3
The effect of silybum marianum in the treatment of tinnitusTinnitusIRCT20160813029327N13Islamic Azad University40
Recruiting
Phase 3
Examination of the effect of silybum marianum on thyroid and antioxidant capacity in patients with bipolar disorders under the treatment of lithiumPatients with bipolar disorder.Bipolar disorderIRCT20190811044513N2Hamedan University of Medical Sciences40